IP Library Granted Patent US 10,966,381
Granted Patent B2
US 10,966,381 · App. 15/024,296 · Granted Apr 6, 2021

Haploid embryogenesis

Inventors: Kimberly Boutilier (De Meern, NL); Gerrit Cornelis Angenent (Wageningen, NL); Mercedes Soriano Castan (Monzon, ES); Li Hui (Beijing, CN)
Assignee: STICHTING WAGENINGEN RESEARCH
A01H4/008A01H1/00A01H1/08A01N37/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,966,381
App. No.
15/024,296
Granted
Apr 6, 2021
Kind
B2
Abstract

A switch to haploid embryogenesis is controlled by the activity of histone deacetylases (HDACs). Blocking HDAC activity with HDAC inhibitors (HDACi), e.g. trichostatin A (TSA), in Brassica napus, B. rapa, B. oleracea, Arabidopsis thaliana and Capsicum annuum male gametophytes leads to a large increase in the proportion of cells that undergo embryogenic growth. In B. napus , treatment with one specific HDACi (SAHA) improves the conversion (i.e. germination) of these embryos into seedlings. Existing methods of culturing microspores of angiosperm plants following stress to produce haploid embryos, haploid plants and double haploid plants can be improved by adding HDACi to the culture medium. Advantageously, species hitherto recalcitrant to haploid embryogenesis via microspore culture are rendered useful when using HDACi. Haploid and double haploid plants are of industrial application in the plant breeding programmes.

Claims (3)

1. A method of producing a haploid plant embryo comprising culturing or growing haploid plant material in the presence of a hydroxamic acid compound, wherein the hydroxamic acid compound is chosen from trichostatin A, suberoylanilide hydroxamic acid, suberoyl bis-hydroxamic acid, scriptaid, oxamflatin, tubacin, APHA Compound 8, and apicidin.

2. The method of claim 1 , wherein the hydroxamic compound has histone deacetylase inhibitor activity.

3. The method of claim 1 , wherein the hydroxamic acid compound has haploid embryogenesis activity.

Assignments (2)
CHANGE OF NAME Recorded Dec 6, 2016
From: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
To: STICHTING WAGENINGEN RESEARCH
Reel/Frame 040832/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: BOUTILIER, KIMBERLY; ANGENENT, GERRIT CORNELIS; CASTAN, MERCEDES SORIANO; HUI, LI
To: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
Reel/Frame 038279/0186 →
Priority Claims (1)
WO PCT/EP2013/069851 · Sep 24, 2013 · international
Continuity (1)
Related Publication 20160212956A1 · Jul 28, 2016
Cited By (1)
US 12,408,605